Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sharp Fluidics is a medical device company focused on enhancing surgical safety and operating room efficiency through innovative suture and needle management technologies. The company's flagship products include the NeoClose port closure system and the Suture-Safe automated suture management device, which are designed to streamline minimally invasive procedures. By reducing the risk of needlestick injuries and simplifying complex closure tasks, Sharp Fluidics provides solutions that benefit both surgical teams and patients. The company is headquartered in the San Francisco Bay Area and continues to expand its portfolio of surgical site management tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sharp Fluidics.